Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
/
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Wolters Kluwer N.V. is a Dutch multinational company specializing in professional information, software, AI solutions, and services for accountants, doctors, lawyers, and other experts. It primarily supports sectors including legal, business, tax, accounting, finance, audit, risk, compliance, healthcare, and environmental, health, safety, sustainability (ESG). Notable products encompass UpToDate for clinical decision support, CCH for tax and accounting, Enablon for risk management, CT Corporation for compliance, Lippincott and Ovid for medical publishing, CCH Tagetik for corporate performance, and TeamMate+ for internal controls. Headquartered in Alphen aan den Rijn, Netherlands, the company operates through five divisions: Legal & Regulatory, Tax & Accounting, Health, Financial & Corporate Compliance, and Corporate Performance & ESG, serving over 180 countries. Founded from mergers tracing back to 1836, Wolters Kluwer has expanded globally via strategic acquisitions, emphasizing innovation in AI-powered tools like Libra Legal AI Workspace. Recognized on the Dow Jones Sustainability Index, it plays a pivotal role in empowering professionals with authoritative insights and technology for informed decision-making across industries.
€55.82
€0.44 (-0.78%)
EOD Jun 25, 2026 · Twelve Data
Margins and capital returns are both well above average: 27.54% operating margin, ROIC at 23.59%. Consistent with durable pricing power, though that alone doesn't make it a buy.
Revenue grew 3.5%, steady but not accelerating.
Even for strong businesses, today's 10x P/E means the stock needs to keep delivering. There's no margin of safety if growth disappoints.
9.9x earnings, 9.5x FCF. The multiple is below average. Either the market is pricing in deterioration you should investigate, or there's genuine value here.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
€6.13B
▲ +3.5% YoY
Net Income (TTM)
€1.31B
▲ +21.2% YoY
Op. Margin
27.54%
▲ +0.5pp YoY
ROIC
23.59%
▲ +1.0pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
€1.36B
▲ +1.7% YoY
Op. Cash Flow (TTM)
€1.45B
▲ +8.0% YoY
Net Debt
€4.00B
Cash & Equiv.
€932M
3Y CAGR: +3.9%
3Y CAGR: +1.9%
Continue Research
At a P/E of 9.9 and a price-to-free-cash-flow of 9.5, Wolters Kluwer (WKL.XAMS) trades below a two-stage DCF intrinsic value of about €107.57 per share, so at €55.82 the stock looks undervalued (92.7% below estimated intrinsic value). A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, Wolters Kluwer scores 68/100 on Intrinsiqq's quality scorecard (a solid business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. It currently yields about 4.4%; see dividend safety for coverage and history. All figures are computed from SEC filings; read the full methodology. This is analysis, not investment advice.
Intrinsiqq's two-stage DCF estimates an intrinsic value of about €107.57 per share for WKL.XAMS, projecting its recent free cash flow forward with a growth rate that fades toward a long-run rate and discounting it back to today. Applying a 25% margin of safety gives a more conservative fair-value entry around €80.68. At today's €55.82, that puts the stock about 92.7% below estimated intrinsic value. The result is sensitive to the growth and discount-rate inputs, so it is best to run conservative, base and optimistic cases. You can adjust all of them yourself with the sliders on the DCF tab.
Wolters Kluwer scores 68 out of 100 on Intrinsiqq's quality score, a weighted blend of 8 metrics each scored 0 to 100, which makes it a solid business on these measures. Recent fundamentals include a 27.5% operating margin and a 23.6% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
Yes, Wolters Kluwer pays a regular dividend of about €2.44 per share per year (typically in quarterly installments), a yield of roughly 4.4% at the current price. That is a payout ratio of about 43.0% of earnings, so the dividend is well covered. Wolters Kluwer has grown the dividend at roughly 10.8% a year over the past few years. A low headline yield is not the same as a weak dividend: what matters is how well earnings and free cash flow cover the payout and whether it is growing, not the percentage alone. For WKL.XAMS's full payout history, growth streak and dividend-safety score, see the dividends tab.
That depends on valuation and quality together, not either alone. WKL.XAMS currently trades below its estimated intrinsic value and scores 68/100 on quality (solid). It also yields about 4.4%. A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.